You have free access to this content

Hepatology

Cover image for Vol. 52 Issue 3

September 2010

Volume 52, Issue 3

Pages 807–1176

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection (pages 822–832)

      Andrew J. Muir, Mitchell L. Shiffman, Atif Zaman, Boris Yoffe, Andrew de la Torre, Steven Flamm, Stuart C. Gordon, Paul Marotta, John M. Vierling, Juan Carlos Lopez-Talavera, Kelly Byrnes-Blake, David Fontana, Jeremy Freeman, Todd Gray, Diana Hausman, Naomi N. Hunder and Eric Lawitz

      Article first published online: 14 MAY 2010 | DOI: 10.1002/hep.23743

    2. You have free access to this content
      Outcome of sustained virological responders with histologically advanced chronic hepatitis C (pages 833–844)

      Timothy R. Morgan, Marc G. Ghany, Hae-Young Kim, Kristin K. Snow, Mitchell L. Shiffman, Jennifer L. De Santo, William M. Lee, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Jules L. Dienstag, Chihiro Morishima, Karen L. Lindsay, Anna S. F. Lok and and the HALT-C Trial Group

      Article first published online: 14 MAY 2010 | DOI: 10.1002/hep.23744

    3. You have free access to this content
      Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA (pages 845–853)

      Zong-Gen Peng, Bo Fan, Na-Na Du, Yu-Ping Wang, Li-Mei Gao, Ying-Hong Li, Yu-Huan Li, Fei Liu, Xue-Fu You, Yan-Xing Han, Zhi-Yun Zhao, Shan Cen, Jian-Rui Li, Dan-Qing Song and Jian-Dong Jiang

      Article first published online: 18 MAY 2010 | DOI: 10.1002/hep.23766

    4. You have free access to this content
      Associations between serum lipids and hepatitis C antiviral treatment efficacy (pages 854–863)

      Darmendra Ramcharran, Abdus S. Wahed, Hari S. Conjeevaram, Rhobert W. Evans, Tianyi Wang, Steven H. Belle, Leland J. Yee and for the Virahep-C Study Group

      Article first published online: 11 JUN 2010 | DOI: 10.1002/hep.23796

    5. You have free access to this content
      Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy (pages 864–874)

      Stephen A. Harrison, Lorenzo Rossaro, Ke-Qin Hu, Keyur Patel, Hans Tillmann, Sandeep Dhaliwal, Dawn M. Torres, Kenneth Koury, Venkata S. Goteti, Stephanie Noviello, Clifford A. Brass, Janice K. Albrecht, John G. McHutchison and Mark S. Sulkowski

      Article first published online: 1 JUN 2010 | DOI: 10.1002/hep.23787

    6. You have free access to this content
      Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells (pages 875–885)

      Avidan U. Neumann, Sandra Phillips, Idit Levine, Samreen Ijaz, Harel Dahari, Rachel Eren, Shlomo Dagan and Nikolai V. Naoumov

      Article first published online: 25 MAY 2010 | DOI: 10.1002/hep.23778

    7. You have free access to this content
      Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B (pages 886–893)

      Ting-Tsung Chang, Yun-Fan Liaw, Shun-Sheng Wu, Eugene Schiff, Kwang-Hyub Han, Ching-Lung Lai, Rifaat Safadi, Samuel S. Lee, Waldemar Halota, Zachary Goodman, Yun-Chan Chi, Hui Zhang, Robert Hindes, Uchenna Iloeje, Suzanne Beebe and Bruce Kreter

      Article first published online: 1 JUN 2010 | DOI: 10.1002/hep.23785

  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
    2. You have free access to this content
      PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease (pages 904–912)

      Elizabeth K. Speliotes, Johannah L. Butler, Cameron D. Palmer, Benjamin F. Voight, the GIANT Consortium the MIGen Consortium, the NASH CRN and Joel N. Hirschhorn

      Article first published online: 18 MAY 2010 | DOI: 10.1002/hep.23768

    3. You have free access to this content
      Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease (pages 913–924)

      Brent A. Neuschwander-Tetri, Jeanne M. Clark, Nathan M. Bass, Mark L. Van Natta, Aynur Unalp-Arida, James Tonascia, Claudia O. Zein, Elizabeth M. Brunt, David E. Kleiner, Arthur J. McCullough, Arun J. Sanyal, Anna Mae Diehl, Joel E. Lavine, Naga Chalasani, Kris V. Kowdley and NASH Clinical Research Network

      Article first published online: 1 JUN 2010 | DOI: 10.1002/hep.23784

    4. You have free access to this content
      HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 μg/L are at low risk of hemochromatosis (pages 925–933)

      Katrina J. Allen, Nadine A. Bertalli, Nicholas J. Osborne, Clare C. Constantine, Martin B. Delatycki, Amy E. Nisselle, Amanda J. Nicoll, Dorota M. Gertig, Christine E. McLaren, Graham G. Giles, John L. Hopper, Gregory J. Anderson, John K. Olynyk, Lawrie W. Powell, Lyle C. Gurrin and for the HealthIron Study Investigators

      Article first published online: 1 JUN 2010 | DOI: 10.1002/hep.23786

    5. You have free access to this content
      High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis (pages 934–944)

      Rohit Kohli, Michelle Kirby, Stavra A. Xanthakos, Samir Softic, Ariel E. Feldstein, Vijay Saxena, Peter H. Tang, Lili Miles, Michael V. Miles, William F. Balistreri, Stephen C. Woods and Randy J. Seeley

      Article first published online: 11 JUN 2010 | DOI: 10.1002/hep.23797

  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion (pages 945–953)

      Wei Ding, Hanning You, Hien Dang, Francis LeBlanc, Vivian Galicia, Shelly C. Lu, Bangyan Stiles and C. Bart Rountree

      Article first published online: 16 JUN 2010 | DOI: 10.1002/hep.23748

    2. You have free access to this content
  5. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth (pages 966–974)

      Serif Senturk, Mine Mumcuoglu, Ozge Gursoy-Yuzugullu, Burcu Cingoz, Kamil Can Akcali and Mehmet Ozturk

      Article first published online: 18 MAY 2010 | DOI: 10.1002/hep.23769

  6. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy (pages 975–986)

      Zichen Zhang, Regina A. Oyesanya, Deanna J. W. Campbell, Jorge A. Almenara, Jennifer L. DeWitt and Alphonse E. Sirica

      Article first published online: 20 MAY 2010 | DOI: 10.1002/hep.23773

  7. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis (pages 987–998)

      Ana Lleo, Christopher L. Bowlus, Guo-Xiang Yang, Pietro Invernizzi, Mauro Podda, Judy Van de Water, Aftab A. Ansari, Ross L. Coppel, Howard J. Worman, Gregory J. Gores and M. Eric Gershwin

      Article first published online: 1 JUN 2010 | DOI: 10.1002/hep.23783

    2. You have free access to this content
      A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis (pages 999–1007)

      Silvia Ferri, Maria Serena Longhi, Chiara De Molo, Claudine Lalanne, Paolo Muratori, Alessandro Granito, Munther J. Hussain, Yun Ma, Marco Lenzi, Giorgina Mieli-Vergani, Francesco B. Bianchi, Diego Vergani and Luigi Muratori

      Article first published online: 11 JUN 2010 | DOI: 10.1002/hep.23792

  8. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation (pages 1008–1016)

      Alexander Dechêne, Jan-Peter Sowa, Robert K. Gieseler, Christoph Jochum, Lars P. Bechmann, Amr El Fouly, Martin Schlattjan, Fuat Saner, Hideo A. Baba, Andreas Paul, Volker Dries, Margarethe Odenthal, Guido Gerken, Scott L. Friedman and Ali Canbay

      Article first published online: 14 MAY 2010 | DOI: 10.1002/hep.23754

  9. Liver Failure, Cirrhosis and Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites (pages 1017–1022)

      Thomas Sersté, Christian Melot, Claire Francoz, François Durand, Pierre-Emmanuel Rautou, Dominique Valla, Richard Moreau and Didier Lebrec

      Article first published online: 25 MAY 2010 | DOI: 10.1002/hep.23775

  10. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice (pages 1023–1032)

      Svitlana Kurinna, Sabrina A. Stratton, Wen-Wei Tsai, Kadir C. Akdemir, Weisong Gu, Pallavi Singh, Triona Goode, Gretchen J. Darlington and Michelle Craig Barton

      Article first published online: 16 JUN 2010 | DOI: 10.1002/hep.23746

    2. You have free access to this content
    3. You have free access to this content
      Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration (pages 1046–1059)

      Fatima Teixeira-Clerc, Marie-Pierre Belot, Sylvie Manin, Vanessa Deveaux, Thomas Cadoudal, Marie-Noele Chobert, Alexandre Louvet, Andreas Zimmer, Thierry Tordjmann, Ariane Mallat and Sophie Lotersztajn

      Article first published online: 25 MAY 2010 | DOI: 10.1002/hep.23779

    4. You have free access to this content
      Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice (pages 1060–1067)

      Bowen Liu, Aaron W. Bell, Shirish Paranjpe, William C. Bowen, Jaspal S. Khillan, Jian-Hua Luo, Wendy M. Mars and George K. Michalopoulos

      Article first published online: 11 JUN 2010 | DOI: 10.1002/hep.23794

  11. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
    2. You have free access to this content
      A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with α1-antitrypsin deficiency (pages 1078–1088)

      Elena Miranda, Juan Pérez, Ugo I. Ekeowa, Nedim Hadzic, Noor Kalsheker, Bibek Gooptu, Bernard Portmann, Didier Belorgey, Marian Hill, Susan Chambers, Jeff Teckman, Graeme J. Alexander, Stefan J. Marciniak and David A. Lomas

      Article first published online: 14 MAY 2010 | DOI: 10.1002/hep.23760

    3. You have free access to this content
      p130Cas, Crk-associated substrate plays essential roles in liver development by regulating sinusoidal endothelial cell fenestration (pages 1089–1099)

      Tatsuya Tazaki, Takaaki Sasaki, Kenta Uto, Norimasa Yamasaki, Satoshi Tashiro, Ryuichi Sakai, Minoru Tanaka, Hideaki Oda, Zen-Ichiro Honda and Hiroaki Honda

      Article first published online: 18 MAY 2010 | DOI: 10.1002/hep.23767

    4. You have free access to this content
      Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation (pages 1100–1110)

      Bert-Jan F. de Rooij, Bart van Hoek, W. Rogier ten Hove, Anja Roos, Lee H. Bouwman, Alexander F. Schaapherder, Robert J. Porte, Mohamed R. Daha, Johan J. van der Reijden, Minneke J. Coenraad, Jan Ringers, Andrzej G. Baranski, Bouke G. Hepkema, Daniel W. Hommes and Hein W. Verspaget

      Article first published online: 1 JUN 2010 | DOI: 10.1002/hep.23782

    5. You have free access to this content
      Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in Mice (pages 1111–1123)

      Tetsuhiro Chiba, Atsuyoshi Seki, Ryutaro Aoki, Hitoshi Ichikawa, Masamitsu Negishi, Satoru Miyagi, Hideyuki Oguro, Atsunori Saraya, Akihide Kamiya, Hiromitsu Nakauchi, Osamu Yokosuka and Atsushi Iwama

      Article first published online: 11 JUN 2010 | DOI: 10.1002/hep.23793

  12. Special Article

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Expanding access to hepatitis C virus treatment—Extension for Community Healthcare Outcomes (ECHO) project: Disruptive innovation in specialty care (pages 1124–1133)

      Sanjeev Arora, Summers Kalishman, Karla Thornton, Denise Dion, Glen Murata, Paulina Deming, Brooke Parish, John Brown, Miriam Komaromy, Kathleen Colleran, Arthur Bankhurst, Joanna Katzman, Michelle Harkins, Luis Curet, Ellen Cosgrove and Wesley Pak

      Article first published online: 11 JUN 2010 | DOI: 10.1002/hep.23802

  13. Rapid Communication

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
  14. Reviews

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
    2. You have free access to this content
  15. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
    2. You have free access to this content
  16. Image of the Month

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      The “von Meyenburg complex” (pages 1167–1168)

      Michael Quentin and Axel Scherer

      Article first published online: 20 MAY 2010 | DOI: 10.1002/hep.23772

  17. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Generation of human induced pluripotent stem cells from liver progenitor cells by only small molecules (page 1169)

      Moriguchi Hisashi, Chung Raymond T., Mihara Makoto and Sato Chifumi

      Article first published online: 29 JUL 2010 | DOI: 10.1002/hep.23851

    2. You have free access to this content
      Reply: (pages 1169–1170)

      Hua Liu, Yonghak Kim, Saul Sharkis, Zhaohui Ye and Yoon-Young Jang

      Article first published online: 29 JUL 2010 | DOI: 10.1002/hep.23871

    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
      Optimal dosage of ribavirin (pages 1173–1174)

      Alessandra Mangia and Angelo Andriulli

      Article first published online: 14 MAY 2010 | DOI: 10.1002/hep.23742

    8. You have free access to this content
      Treating fatty liver for the prevention of cardiovascular diseases (pages 1174–1175)

      Federico Salamone, Fabio Galvano and Giovanni Li Volti

      Article first published online: 14 MAY 2010 | DOI: 10.1002/hep.23741

  18. Corrections

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Liver Biology/Pathobiology
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Failure, Cirrhosis and Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. Special Article
    14. Rapid Communication
    15. Reviews
    16. Hepatology Elsewhere
    17. Image of the Month
    18. Correspondence
    19. Corrections
    1. You have free access to this content
      Correction (page 1176)

      Article first published online: 27 AUG 2010 | DOI: 10.1002/hep.23877

      This article corrects:

SEARCH

SEARCH BY CITATION